G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight
The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.
The acquisition of the Johns Hopkins spin out and its liquid biopsy ctDNA test will significantly strengthen Quest’s oncology offerings.
Enzo recently announced that it is selling its lab division to LabCorp for $146 million in cash.
A recently released report estimates that the US market will grow at a CAGR of 4.2 percent over the next seven years.